{
  "spec_version": "4",
  "endpoint": "financials-segment",
  "stock_code": "4928",
  "company_name": "ノエビアホールディングス",
  "content_lang": "ja",
  "meta_lang": "en",
  "canonical_url": "https://the-shashi.com/tse/4928/current/#revenue-mix",
  "api_url": "/api/4928/financials/segment.json",
  "updated": "2026-09-19",
  "license": "© 2026 Yutaka Sugiura. All rights reserved.",
  "attribution": "The社史 (the-shashi.com) — https://the-shashi.com/tse/4928/current/#revenue-mix",
  "source": {
    "segment": {
      "primary": [
        "有価証券報告書（セグメント情報）"
      ],
      "extraction": "EDINET の XBRL から機械抽出",
      "caveat": "セグメント区分は各期の開示区分をそのまま採録しており、期をまたいだ区分の連続性は保証しない"
    },
    "region": {
      "primary": [
        "有価証券報告書（所在地別・海外売上高）"
      ],
      "extraction": "EDINET の XBRL から機械抽出",
      "caveat": "地域区分は各期の開示区分をそのまま採録している"
    }
  },
  "html_url": "https://the-shashi.com/tse/4928/current/#revenue-mix",
  "segment": [
    {
      "FY": "FY16",
      "period": "2016/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化粧品事業",
      "sales": 36031,
      "profit": 9537,
      "assets": 57521
    },
    {
      "FY": "FY16",
      "period": "2016/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬・食品事業",
      "sales": 13243,
      "profit": 170,
      "assets": 22729
    },
    {
      "FY": "FY17",
      "period": "2017/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化粧品事業",
      "sales": 39197,
      "profit": 11002,
      "assets": 57236
    },
    {
      "FY": "FY17",
      "period": "2017/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬・食品事業",
      "sales": 13488,
      "profit": 745,
      "assets": 22903
    },
    {
      "FY": "FY18",
      "period": "2018/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化粧品事業",
      "sales": 42616,
      "profit": 12155,
      "assets": 53181
    },
    {
      "FY": "FY18",
      "period": "2018/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬・食品事業",
      "sales": 13199,
      "profit": 1309,
      "assets": 20062
    },
    {
      "FY": "FY19",
      "period": "2019/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "その他",
      "sales": 2041,
      "profit": 70,
      "assets": 2388
    },
    {
      "FY": "FY19",
      "period": "2019/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化粧品事業",
      "sales": 45175,
      "profit": 13183,
      "assets": 55310
    },
    {
      "FY": "FY19",
      "period": "2019/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬・食品事業",
      "sales": 12036,
      "profit": 1312,
      "assets": 17823
    },
    {
      "FY": "FY20",
      "period": "2020/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "その他",
      "sales": 1825,
      "profit": 10,
      "assets": 2498
    },
    {
      "FY": "FY20",
      "period": "2020/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化粧品事業",
      "sales": 38742,
      "profit": 9505,
      "assets": 53553
    },
    {
      "FY": "FY20",
      "period": "2020/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬・食品事業",
      "sales": 11273,
      "profit": 1261,
      "assets": 16249
    },
    {
      "FY": "FY21",
      "period": "2021/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "その他",
      "sales": 1828,
      "profit": 156,
      "assets": 2474
    },
    {
      "FY": "FY21",
      "period": "2021/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化粧品事業",
      "sales": 38325,
      "profit": 9600,
      "assets": 53400
    },
    {
      "FY": "FY21",
      "period": "2021/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬・食品事業",
      "sales": 11117,
      "profit": 1442,
      "assets": 17422
    },
    {
      "FY": "FY22",
      "period": "2022/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化粧品事業",
      "sales": 47032,
      "profit": 10814,
      "assets": 50596
    },
    {
      "FY": "FY22",
      "period": "2022/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬・食品事業",
      "sales": 11408,
      "profit": 1157,
      "assets": 16753
    },
    {
      "FY": "FY23",
      "period": "2023/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化粧品事業",
      "sales": 48175,
      "profit": 11867,
      "assets": 50047
    },
    {
      "FY": "FY23",
      "period": "2023/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬・食品事業",
      "sales": 11985,
      "profit": 1185,
      "assets": 16879
    },
    {
      "FY": "FY24",
      "period": "2024/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化粧品事業",
      "sales": 49761,
      "profit": 12226,
      "assets": 50654
    },
    {
      "FY": "FY24",
      "period": "2024/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬・食品事業",
      "sales": 11443,
      "profit": 1230,
      "assets": 15629
    },
    {
      "FY": "FY25",
      "period": "2025/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化粧品事業",
      "sales": 50525,
      "profit": 12292,
      "assets": 50423
    },
    {
      "FY": "FY25",
      "period": "2025/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬・食品事業",
      "sales": 11535,
      "profit": 980,
      "assets": 14333
    }
  ],
  "region": [
    {
      "FY": "FY18",
      "period": "2018/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": null,
      "sales": null
    },
    {
      "FY": "FY19",
      "period": "2019/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": null,
      "sales": null
    },
    {
      "FY": "FY20",
      "period": "2020/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": null,
      "sales": null
    },
    {
      "FY": "FY21",
      "period": "2021/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": null,
      "sales": null
    },
    {
      "FY": "FY22",
      "period": "2022/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": null,
      "sales": null
    },
    {
      "FY": "FY23",
      "period": "2023/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": null,
      "sales": null
    },
    {
      "FY": "FY24",
      "period": "2024/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": null,
      "sales": null
    },
    {
      "FY": "FY25",
      "period": "2025/9",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": null,
      "sales": null
    }
  ]
}